These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23188198)

  • 1. ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression.
    Singh AB; Bousman CA; Ng CH; Byron K; Berk M
    Transl Psychiatry; 2012 Nov; 2(11):e198. PubMed ID: 23188198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorder.
    Simoons M; Mulder H; Appeldoorn JTY; Risselada AJ; Schene AH; van Schaik RHN; van Roon EN; Ruhé EG
    Psychiatr Genet; 2020 Feb; 30(1):19-29. PubMed ID: 31634334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder.
    Kato M; Fukuda T; Serretti A; Wakeno M; Okugawa G; Ikenaga Y; Hosoi Y; Takekita Y; Mandelli L; Azuma J; Kinoshita T
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):398-404. PubMed ID: 17913323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between the functional polymorphism (C3435T) of the gene encoding P-glycoprotein (ABCB1) and major depressive disorder in the Japanese population.
    Fujii T; Ota M; Hori H; Sasayama D; Hattori K; Teraishi T; Yamamoto N; Hashikura M; Tatsumi M; Higuchi T; Kunugi H
    J Psychiatr Res; 2012 Apr; 46(4):555-9. PubMed ID: 22306099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCB1 Gene Variants and Antidepressant Treatment Outcomes: A Systematic Review and Meta-Analysis Including Results from the CAN-BIND-1 Study.
    Magarbeh L; Hassel C; Choi M; Islam F; Marshe VS; Zai CC; Zuberi R; Gammal RS; Men X; Scherf-Clavel M; Enko D; Frey BN; Milev R; Soares CN; Parikh SV; Placenza F; Strother SC; Hassel S; Taylor VH; Leri F; Blier P; Farzan F; Lam RW; Turecki G; Foster JA; Rotzinger S; Kloiber S; Kennedy JL; Kennedy SH; Bousman CA; Müller DJ
    Clin Pharmacol Ther; 2023 Jul; 114(1):88-117. PubMed ID: 36681895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.
    Nikisch G; Eap CB; Baumann P
    Pharmacol Res; 2008; 58(5-6):344-7. PubMed ID: 18940259
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Santos M; Lima L; Carvalho S; Brandão A; Barroso F; Cruz A; Medeiros R
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin transporter gene polymorphism associated with short-term treatment response to venlafaxine.
    Lee SH; Choi TK; Lee E; Seok JH; Lee SH; Lee HS; Kim SJ
    Neuropsychobiology; 2010 Aug; 62(3):198-206. PubMed ID: 20664233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetic polymorphisms and response to escitalopram and venlafaxine over 8 weeks in major depression.
    Ng C; Sarris J; Singh A; Bousman C; Byron K; Peh LH; Smith DJ; Tan CH; Schweitzer I
    Hum Psychopharmacol; 2013 Sep; 28(5):516-22. PubMed ID: 24014145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein (PGP) polymorphisms and sexual dysfunction in female patients with depression and SSRI-associated sexual side effects.
    Bly MJ; Bishop JR; Thomas KL; Ellingrod VL
    J Sex Marital Ther; 2013; 39(3):280-8. PubMed ID: 23356581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ABCB1 (MDR1) predicts remission on P-gp substrates in chronic depression.
    Ray A; Tennakoon L; Keller J; Sarginson JE; Ryan HS; Murphy GM; Lazzeroni LC; Trivedi MH; Kocsis JH; DeBattista C; Schatzberg AF
    Pharmacogenomics J; 2015 Aug; 15(4):332-9. PubMed ID: 25487678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of ABCB1 polymorphisms and serum concentrations on venlafaxine response in patients with major depressive disorder.
    Ozbey G; Celikel FC; Cumurcu BE; Kan D; Yucel B; Hasbek E; Percin F; Guzey IC; Uluoglu C
    Nord J Psychiatry; 2017 Apr; 71(3):230-237. PubMed ID: 28079463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB1 C3435T polymorphism is associated with susceptibility to major depression, but not with a clinical response to citalopram in a Turkish population.
    Ozbey G; Yucel B; Taycan SE; Kan D; Bodur NE; Arslan T; Percin F; Yuksel N; Guzey C; Uluoglu C
    Pharmacol Rep; 2014 Apr; 66(2):235-8. PubMed ID: 24911075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between serotonin transporter-linked polymorphic region and escitalopram antidepressant treatment response in Korean patients with major depressive disorder.
    Won ES; Chang HS; Lee HY; Ham BJ; Lee MS
    Neuropsychobiology; 2012; 66(4):221-9. PubMed ID: 23095326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis.
    Breitenstein B; Brückl TM; Ising M; Müller-Myhsok B; Holsboer F; Czamara D
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):274-83. PubMed ID: 25847751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ABCB1 gene variants influence tolerance to selective serotonin reuptake inhibitors in a large sample of Dutch cases with major depressive disorder.
    de Klerk OL; Nolte IM; Bet PM; Bosker FJ; Snieder H; den Boer JA; Bruggeman R; Hoogendijk WJ; Penninx BW
    Pharmacogenomics J; 2013 Aug; 13(4):349-53. PubMed ID: 22641028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCB6, ABCB1 and ABCG1 genetic polymorphisms and antidepressant response of SSRIs in Chinese depressive patients.
    Huang X; Yu T; Li X; Cao Y; Li X; Liu B; Yang F; Li W; Zhao X; Feng G; Zhang X; Dong Z; He L; Sun X; He G
    Pharmacogenomics; 2013 Nov; 14(14):1723-30. PubMed ID: 24192121
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Gao YL; He B
    DNA Cell Biol; 2018 Dec; 37(12):1055-1060. PubMed ID: 30256659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.
    Kennedy SH; Andersen HF; Lam RW
    J Psychiatry Neurosci; 2006 Mar; 31(2):122-31. PubMed ID: 16575428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
    Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
    Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.